1. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice. Babaev VR, Yeung M, Erbay E, Ding L, Zhang Y, May JM, Fazio S, Hotamisligil GS, Linton MF (2016) Arterioscler Thromb Vasc Biol 36(6): 1122-31
    › Primary publication · 27102962 (PubMed) · PMC4882236 (PubMed Central)
  2. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms. Tavori H, Giunzioni I, Predazzi IM, Plubell D, Shivinsky A, Miles J, Devay RM, Liang H, Rashid S, Linton MF, Fazio S (2016) Cardiovasc Res 110(2): 268-78
    › Primary publication · 26980204 (PubMed) · PMC4836631 (PubMed Central)
  3. HDL: Beyond Atheroprotection. Kon V, Linton MF (2016) J Am Soc Nephrol 27(2): 341-4
    › Primary publication · 26319243 (PubMed) · PMC4731133 (PubMed Central)
  4. Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis. Ormseth MJ, Yancey PG, Solus JF, Bridges SL, Curtis JR, Linton MF, Fazio S, Davies SS, Roberts LJ, Vickers KC, Kon V, Michael Stein C, TETRAD Investigators (2016) Arthritis Rheumatol 68(9): 2099-105
    › Primary publication · 26991245 (PubMed) · PMC5001900 (PubMed Central)
  5. Uric acid correlates to oxidation and inflammation in opposite directions in women. Wu SH, Shu XO, Milne G, Xiang YB, Zhang X, Cai Q, Fazio S, Linton MF, Chen H, Purdue M, Rothman N, Gao YT, Zheng W, Yang G (2015) Biomarkers 20(4): 225-31
    › Primary publication · 26301880 (PubMed) · PMC4989504 (PubMed Central)
  6. Sex-Specific Parental Effects on Offspring Lipid Levels. Predazzi IM, Sobota RS, Sanna S, Bush WS, Bartlett J, Lilley JS, Linton MF, Schlessinger D, Cucca F, Fazio S, Williams SM (2015) J Am Heart Assoc 4(7)
    › Primary publication · 26126546 (PubMed) · PMC4608079 (PubMed Central)
  7. Response to letter regarding article, "Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms". Rashid S, Tavori H, Brown PE, Linton MF, He J, Giunzioni I, Fazio S (2015) Circulation 131(18): e428
    › Primary publication · 25940973 (PubMed) · PMC4547604 (PubMed Central)
  8. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis. Tao H, Yancey PG, Babaev VR, Blakemore JL, Zhang Y, Ding L, Fazio S, Linton MF (2015) J Lipid Res 56(8): 1449-60
    › Primary publication · 26059978 (PubMed) · PMC4513986 (PubMed Central)
  9. Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL. Tavori H, Su YR, Yancey PG, Giunzioni I, Wilhelm AJ, Blakemore JL, Zabalawi M, Linton MF, Sorci-Thomas MG, Fazio S (2015) J Lipid Res 56(3): 635-43
    › Primary publication · 25593328 (PubMed) · PMC4340310 (PubMed Central)
  10. Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts. Guo L, Chen Z, Amarnath V, Yancey PG, Van Lenten BJ, Savage JR, Fazio S, Linton MF, Davies SS (2015) Antioxid Redox Signal 22(18): 1633-45
    › Primary publication · 25751734 (PubMed) · PMC4485367 (PubMed Central)